The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

bioasborbabletx.com

Bioabsorbable Therapeutics has not claimed their Profile.

Want to better differentiate Bioabsorbable Therapeutics between your competitors? Show buyers how.

Reva Medical company logo

Why does Bioabsorbable Therapeutics win vs. Reva Medical?

Show Bioabsorbable Therapeutics's primary competitive advantage
Show Bioabsorbable Therapeutics's competitive differentiation

Bioabsorbable Therapeutics's alternatives and competitors

See how Bioabsorbable Therapeutics compares to similar products. Bioabsorbable Therapeutics's top competitors include Reva Medical, Endologix, and Microfabrica.

REVA Medical develops interventional medical devices that leverage the company's stent designs and biomaterials to improve the treatment of vascular disease. Its flagsh…

Bioabsorbable Therapeutics vs. Reva Medical

View more in-depth data on:

  • Competitors
  • Products
  • Customer References and more
  • Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented…

    Bioabsorbable Therapeutics vs. Endologix

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Microfabrica is working to develop technology for the production of micro-machines and other micro-scale device. The company's flagship technology, EFAB, is designed to…

    Bioabsorbable Therapeutics vs. Microfabrica

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • TriVascular has developed numerous design and manufacturing technologies in pursuit of its commitment to providing optimal solutions for endovascular aortic repair (EVA…

    Bioabsorbable Therapeutics vs. TriVascular Technologies

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Veryan is developing innovative solutions to improve the performance of vascular stents using the principles of biomimicry. Veryan's BioMimics 3D stent technology invol…

    Bioabsorbable Therapeutics vs. Veryan Medical

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • TriReme Medical is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices fo…

    Bioabsorbable Therapeutics vs. TriReme Medical

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • NovoStent Corporation is a medical device company developing: Stenting of atherosclerotic lesion(s).NovoStent is leading the way into the new dimension of stenting.

    Bioabsorbable Therapeutics vs. Novostent

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • The company's FiberHalo stent deployment catheter will enable the physician to deploy the stent and measure in-stent lumen area during the procedure. The FiberHalo post…

    Bioabsorbable Therapeutics vs. CorNova

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Devax is a medical device company engaged in the development of a proprietary drug eluting stent system that aims to provide a clinical solution to treat coronary, caro…

    Bioabsorbable Therapeutics vs. Devax

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Coapt Systems Inc. designs, develops and markets innovative bioabsorbable products for facial rejuvenation procedures in aesthetic and reconstructive markets. The Compa…

    Bioabsorbable Therapeutics vs. Coapt Systems

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Cardiomind is developing innovative small diameter delivery devices and stents potentially useful in treating a variety of neurological and cardiovascular disease condi…

    Bioabsorbable Therapeutics vs. CardioMind

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Alveolus is a developer of non- vascular interventional stent technology. Alveolus' stenting technology enhances the quality of life for patients who suffer from pulmon…

    Bioabsorbable Therapeutics vs. Alveolus

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Conor Medsystems, Inc. was acquired by Johnson & Johnson in January 2007. Prior to the acquisition, Conor was developing, manufacturing and marketing next generation dr…

    Bioabsorbable Therapeutics vs. Conor Medsystems

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Based in Menlo Park, California, Xtent Inc. is a privately held developer of next generation drugeluting stent (DES) systems designed for the treatment of real-world pa…

    Bioabsorbable Therapeutics vs. XTENT

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • LuMend, Inc. is developing, manufacturing and marketing medical devices that meet clinical needs in interventional cardiology and radiology. The company's products are…

    Bioabsorbable Therapeutics vs. LuMend

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more
  • Devices for Vascular Interventions offers atherectomy systems for removal of plaque from coronary arteries

    Bioabsorbable Therapeutics vs. Devices for Vascular Intervention

    View more in-depth data on:

    • Competitors
    • Products
    • Customer References and more

Work for Bioabsorbable Therapeutics?

Brief our analysts.

Get in front of tech buyers.

100% free.

No pay-to-play nonsense.

You May Also Like

D
Devices for Vascular Intervention

Devices for Vascular Interventions offers atherectomy systems for removal of plaque from coronary arteries

Endologix Logo
Endologix

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA. Endologix is currently marketing its Powerlink Delivery System a, one-piece endoluminal stent graft (ELG) used in treating AAA that has significant advantages when compared with marketed stent alternatives. Powerlink has been commercially available in Europe since 1999. FDA approval for the Powerlink AAA stent graft was received on October 29, 2004. The Powerlink superior design is covered by 17 U.S. patents with 361 allowed claims; the technology is designed to overcome shortcomings of first-generation ELGs. The device is for sale in the United States and selected international markets. Endologix is a publicly-held company trading on NASDAQ: ELGX. The company's corporate office is located in Irvine, California.

M
Micell Technologies

Micell Technologies aims to bring together the clinical advantages of a drug-eluting stent with the long-term safety and stability of a bare metal stent.

R
Reva Medical

REVA Medical develops interventional medical devices that leverage the company's stent designs and biomaterials to improve the treatment of vascular disease. Its flagship product is called MOTIV, a bioresorbable coronary stent that is designed to fulfill the temporary need for a stent and then fade away, leaving only the healed vessel behind. This product is utilized for the treatment of coronary artery disease. REVA Medical has a broad strategic relationship with Boston Scientific Corporation, a worldwide developer and marketer of interventional medical devices. The company was founded in 1998 and is based in San Diego, California.

Veryan Medical Logo
Veryan Medical

Veryan is developing innovative solutions to improve the performance of vascular stents using the principles of biomimicry. Veryan's BioMimics 3D stent technology involves adapting traditional straight stent designs to a patented three-dimensional helical shape, which more closely mimics the natural geometry of the human vascular system. BioMimics 3D technology has been proven to enhance clinical performance by improving flow conditions in, and the biomechanical performance of, stented vessels. The advanced, biomimetic design of the BioMimics 3D stent is intended to provide improved flow conditions and more flexibility, kink and fracture resistance than other nitinol stents. Veryan's Research & Development facility is located in Galway, Ireland.

T
TriReme Medical

TriReme Medical is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The company is focused on the US and the emerging Asian markets.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.